Iterum Therapeutics PLC (NAS:ITRM)
$ 1.29 -0.03 (-2.27%) Market Cap: 29.29 Mil Enterprise Value: 39.16 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 35/100

Q2 2021 Iterum Therapeutics PLC Earnings Call Transcript

Aug 13, 2021 / 12:30PM GMT
Release Date Price: $9.64 (-4.45%)
Operator

Hello, and welcome to Iterum Therapeutics Q2 Financial Results Conference Call. (Operator Instructions)

I now have the pleasure of handing over to Louise Barrett, Senior Vice President of Legal Affairs.

Louise Barrett
Iterum Therapeutics plc - SVP of Legal Affairs & Secretary

Thank you, Hannah. Good morning, and welcome to Interim Therapeutics Second Quarter 2021 Financial Results and Business Update Conference Call. A press release with the company's second quarter results was issued earlier this morning and can be found on our website.

We are joined this morning by Corey Fishman, CEO; and Judy Matthews, CFO. Corey will provide some opening remarks. Judy will provide details on our financial results, and then we'll open the floor for Q&A.

Before we begin, I'd like to remind you that this call will contain forward-looking statements concerning our plans, strategies and prospects for our business, including with respect to planned interactions and communications with the FDA following receipt of the Complete Response Letter

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot